Benzinga's M&A Chatter for Tuesday January 24, 2012

Loading...
Loading...
The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday January 24, 2012:
Amgen to Acquire DendreonThe Rumor
:

AMGN
AMGN
to acquire Dendreon
DNDN
for $21 per share, according to sources. Dendreon has been a recurring name as a takeover over the past few years. The last chatter involved Novartis back on December 20. CEO Mitch Gold has always indicated in the past he wants Dendreon to remain an independent company. Amgen would not comment on the rumor. A Dendreon spokesperson was not available for comment. Dendreon closed at $13.97 Tuesday, a gain of 5.75% for the day on almost twice the average daily volume.
Range Resources to be Acquired for as Much as $100 Per ShareThe Rumor
:

Range Resources
RRC
will be acquired for as much as $100 per share, according to comments out of Raymond James. Range Resources is a weekly target for chatter. On January 17 it was rumored the company had hired advisors to handle potential bids. Royal Dutch Shell
RDS
has been the name most associated with a takeover of Range Resources. As always, the company will not comment on rumors. Range Resources closed at $57.20 Tuesday, a loss of 3.05% for the day on 1.6 times the average daily volume.
Collective Brands to be AcquiredThe Rumor
:

For the second day in a row, Collective Brands
PSS
was the subject of takeover chatter.
Bloomberg
reported that the parent company of Payless Shoe Source could be worth as much as $27 per share. Potential bidders include
DSW
, PE firm Irving Capital and Leonard Green. A spokesperson for Collective Brands said the company would not comment while undergoing strategic review. Collective Brands closed at $15.89 Tuesday, a gain of 6.36% for the day on more than 2.4 times the average daily volume.
Petroleo Brasileiro to Acquire 35% Stake in TransoceanThe Rumor
:

Petroleo Brasileiro
PBR
to acquire up to a 35% stake in Transocean
RIG
, according to sources. Spokespersons for both Petrobras and Transocean basically denied the rumors, but officially would not comment. Later in the day several major news media said the deal would not happen and Jefferies also made some negative comments regarding a potential deal. Transocean closed at $45.83 Tuesday, a gain of 1.39% for the day on twice the average daily volume.
Arch Coal to Acquire Patriot CoalThe Rumor
Loading...
Loading...
:

Arch Coal
ACI
to acquire Patriot Coal
PCX
for $12.50 per share. The rumor may be attributed to a
press release
from a stock newsletter. Patriot Coal last had takeover talk back on November 2, 2011. Patriot Coal closed at $8.03 Tuesday, a loss of 0.37% for the day on slightly more than the average daily volume.
Johnson & Johnson, Vertex Pharmaceuticals to Acquire Achillion PharmaceuticalsThe Rumor
:

Achillion Pharmaceuticals
ACHN
has retained Merrill Lynch to solicit bids from potential buyers. Rumored buyers include Johnson & Johnson
JNJ
and Vertex Pharmaceuticals
VRTX
, with a target price as high as $24 per share. Achillion last had chatter on January 20, when a survey of investors agreed the company was a potential takeover target. Achillion Pharmaceuticals closed at $10.75 Tuesday, a gain 16.72% for the day on 4.5 times the average daily volume.
Amazon to Acquire Research in MotionThe Rumor
:

Amazon
AMZN
to acquire Research in Motion
RIMM
, according to chatter circulating online. RIMM's new CEO Thorsten Heins, said on Monday the company would listen to potential buyers, though that was not the primary focus. Research in Motion closed at $15.01 Tuesday, a loss of 3.53% for the day on 1.5 times the average daily volume.
Terex Receives BidThe Rumor
:

Terex
TEX
has has received a bid of $30 per share, according to sources. The name of the potential buyer was not mentioned. Terex closed at $19.30 Tuesday, a gain of 3.15% for the day on slightly less than the average daily volume.
Watson Acquires Ascent Pharmahealth for AU$375 MillionThe Deal
:

Watson Pharmaceuticals
WPI
announced Tuesday that it has acquired Ascent Pharmahealth Ltd, the Australia and Southeast Asia generic pharmaceutical business of Strides Arcolab Ltd, for AU$375 million in cash. As a result of the acquisition, Watson becomes the fifth largest generic pharmaceutical company in Australia based on revenue, and the combined company will be the second largest in terms of total molecules. Watson also becomes the largest generics company in Singapore and gains an established commercial base in Malaysia, Hong Kong, Vietnam and Thailand. Watson expects the transaction to be immediately accretive to 2012 non-GAAP earnings. Watson Pharmaceuticals closed at $55.89 Tuesday, a loss of 2.31% for the day on 5.5 times the average daily volume.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Long IdeasNewsShort IdeasRumorsM&AAfter-Hours CenterMoversTechTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...